Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program.
Maines F, De Giorgi U, Procopio G, Facchini G, Fratino L, Sabbatini R, Gasparro D, Basso U, Mosillo C, Campadelli E, Massari F, Sava T, Sirotova S, Messina C, Scagliarini S, Conteduca V, Verzoni E, Rossetti S, Veccia A, Kinspergher S, Caffo O.
Maines F, et al. Among authors: mosillo c.
Future Oncol. 2018 Nov;14(26):2691-2699. doi: 10.2217/fon-2018-0113. Epub 2018 Sep 12.
Future Oncol. 2018.
PMID: 30207488
Clinical Trial.